Degron, CREATE, TenNor raise capital; Cabaletta posts CAR-T data
💸 A Series A extension: US-China biotech Degron Therapeutics has collected an additional $40 million for its molecular glue degrader platform. The San Diego and Shanghai biotech has raised $95 million ...
May 14, 2026 10:42 AM EDT News Briefing A Series A, B and an IPO; Cabaletta reports CAR-T results ENDPOINTS 💸 A Series A extension: US-China biotech Degron Therapeutics has collected an additional $40 million for its molecular glue degrader platform … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that